ArticleJournal of clinical immunology2006

Transduction of primary lymphocytes with Epstein-Barr virus (EBV) latent membrane protein-specific T-cell receptor induces lysis of virus-infected cells: A novel strategy for the treatment of Hodgkin's disease and nasopharyngeal carcinoma.

Lisa A Jurgens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.